Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery
NCT ID: NCT03996889
Last Updated: 2019-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2019-09-30
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study
NCT04429243
Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX)
NCT01961167
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
NCT05143138
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
NCT05811364
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
NCT02080871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Popliteal aneurysm patients with GORE VIABAHN®
The study population will include all popliteal aneurysm patients treated with GORE VIABAHN® stent graft in scheduled elective surgery, whether symptomatic or asymptomatic.
Endovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery
The intervention can be performed under local anesthesia (LA), regional locus (ALR) or general anesthesia (AG) (data collected) by first approach: percutaneous or conventional.
The data collected are:
* Number of GORE VIABAHN® stent used (length and diameter of each)
* Embolization of collaterals and other related actions
* Operative complications
* Intraoperative fibrinolysis
* Collar cover\> 2 cm
* Lack of overlap in the "overlap zone" (nb: between 4 and 8 cm above the joint spacing)
* Arteriography in profile, kink
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery
The intervention can be performed under local anesthesia (LA), regional locus (ALR) or general anesthesia (AG) (data collected) by first approach: percutaneous or conventional.
The data collected are:
* Number of GORE VIABAHN® stent used (length and diameter of each)
* Embolization of collaterals and other related actions
* Operative complications
* Intraoperative fibrinolysis
* Collar cover\> 2 cm
* Lack of overlap in the "overlap zone" (nb: between 4 and 8 cm above the joint spacing)
* Arteriography in profile, kink
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* symptomatic or asymptomatic popliteal artery aneurysm needing surgery
* scheduled elective surgery
Exclusion Criteria
* thrombotic occlusion of popliteal artery
* intolerance to antiplatelet drugs (antiaggregants)
* known allergies to GORE VIABAHN® stent graft materials/composition
* emergency surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital pneumologique et cardiovasculaire Louis Pradel (HCL)
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VAP-AURC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.